A medicinal drug, hydroxychloroquine is primarily utilized for the treatment and prevention for malaria like chloroquine-sensitive malaria. Though it is primarily recognized for malaria, it’s utilized for treating rheumatic disorders such as rheumatoid arthritis, Q fever, porphyria cutanea tarda, and systemic lupus erythematosus. It is also known as hydroxychloroquine sulfate and it is retailed in the brand name of Hydroquin, Plaquenil, Dolquine, Axemal, Quinoric, and Quensyl.
At present, the hydroxychloroquine is observing a rise in demand from many nations as they taking measures to treat COVID-19, or Coronavirus pandemic that has caused so many deaths and the patient pool is increasing rapidly. Clinical trials are in progress and results of these will determine the drug’s demand for prevention and treatment of the lethal viral infection. The antimalarial can be used in blend with a common antibiotic azithromycin, as a possible COVID-19 treatment; nonetheless, its buying is stringently regulated. Thus, the rising product demand due to rising patient pool suffering from coronavirus is expected to drive the growth of the global hydroxychloroquine market in the coming period.
In addition, the rising count of individuals suffering from lupus and arthritis is also projected to boost the expansion of the global market during the forecast period. Further, owing to extensive usage in clinical studies being performed in several research and development units –pharmaceutical companies and universities – a noteworthy demand is witnessed for the drug, which, in turn, is anticipated to pave way for prospects in the upcoming period. Moreover, the growing malaria cases in the underdeveloped and developing nations, comprising African countries and India, further fueled the drug’s production in the recent years.
To cite, in March 2020, Intas Pharmaceuticals Ltd declared to team up with the World Health Organization-authorized research into the prevention of COVID-19 making use of hydroxychloroquine and intends to provide the 2 million hydroxychloroquine tablets for the research.
Get Sample of this Research Report for more Industry Insights – https://www.zionmarketresearch.com/requestbrochure/hydroxychloroquine-market
Audrey has been working with this organization for 3 years now. Initially, started as Junior Content writer now a Senior Content Writer, hard work and dedication have surely paid off. Always keen to take up any new work or challenge and equally interested in social work, Audrey through her writing likes to make people aware of the several health-related issues & solutions. Thereby, Audrey is responsible for the Health domain and writes news, blogs, and reports pertaining to it. This encompasses drug approvals, new drug discoveries, innovation & invention, vaccination reports, news disease outbreaks & measures, clinical trials, and so on.